Co-Diagnostics
NASDAQ: CODXSalt Lake City, US · Founded 2013 · Utah corporation
Founders & leadership
Co-Diagnostics was founded in 2013 by Dwight H. Egan and Brent Satterfield.
DH
Dwight H. EganCo-founder
BS
Brent SatterfieldCo-founder
RL
Reed L. BensonExecutive
Reported raises · per SEC filings
Form D private placements$47.3M disclosed across 2 rounds · 2016–2021
▶$46.6MraisedJan 2022 · 22 investors · BiotechnologyRule 506(b)
▶$46.6MraisedJan 2022 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian BrownExecutive Officer
- Dwight EganExecutive Officer
- Offering amount
- $47.2M
- Amount sold
- $46.6M
- First sale
- Dec 2021
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$750KraisedDec 2016 · 11 investors · BiotechnologyRule 506(b)
▶$750KraisedDec 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Reed L. BensonExecutive Officer, Director
- Dwight H. EganExecutive Officer
- Brent SatterfieldDirector
- Amount sold
- $750K
- First sale
- Dec 2016
- Incorporated
- Corporation, New York, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Co-Diagnostics?
- Co-Diagnostics was founded by Dwight H. Egan, Brent Satterfield in 2013.
- How much funding has Co-Diagnostics raised?
- Co-Diagnostics has disclosed $47.3M raised across 2 rounds.
- Where is Co-Diagnostics headquartered?
- Co-Diagnostics is headquartered in Salt Lake City, US.